BioHealth News Archive

The Washington region is poised to dominate the new biodata industry – Washington Business Journal

The Washington region is poised to dominate the new biodata industry – Washington Business Journal

The Washington region is poised to dominate a new billions-dollar industry. {iframe}http://www.bizjournals.com/washington/print-edition/2016/05/20/the-biodata-gold-rush.html{/iframe}

Read More
Avalon, GSK form 8th San Diego biotech – SanDiegoUnionTribune.com

Avalon, GSK form 8th San Diego biotech – SanDiegoUnionTribune.com

Extending their partnership to an eighth company, La Jolla's Avalon Ventures and UK-based drug giant GSK said Friday they have formed another San Diego…

Read More
STEM education can help boost Baltimore’s economy, Johns Hopkins president says – Hub

STEM education can help boost Baltimore’s economy, Johns Hopkins president says – Hub

Johns Hopkins University President Ronald J. Daniels was among the speakers Thursday at the fifth annual U.S. News & World Report STEM Solutions National…

Read More
Roche VC fund drives genomics sample prep player to $18.2M Series A – FierceBiotech

Roche VC fund drives genomics sample prep player to $18.2M Series A – FierceBiotech

Roche Venture Fund and 5AM Ventures have led Purigen Biosystems to an $18.2 million Series A round. Purigen will use the money to advance…

Read More
Here’s who won this year’s TEDCO ICE Awards – Technical.ly Baltimore

Here’s who won this year’s TEDCO ICE Awards – Technical.ly Baltimore

TEDCO handed out its annual honors for “Innovation,” “Corporate Excellence” and “Entrepreneurship” on Tuesday. The ICE Awards ceremony at Columbus Center in Inner Harbor…

Read More
QIAGEN Extends Tender Offer Period for Acquisition of Exiqon A/S

QIAGEN Extends Tender Offer Period for Acquisition of Exiqon A/S

QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced the extension of the offer period for the acquisition of Exiqon A/S, a world…

Read More
Roche Gets Accelerated Approval for Immunotherapy Drug – Zacks.com

Roche Gets Accelerated Approval for Immunotherapy Drug – Zacks.com

Roche Holding (RHHBY - Analyst Report) announced that the FDA has granted accelerated approval to its cancer immunotherapy drug, Tecentriq (atezolizumab), for the treatment…

Read More
People who live the longest share these personality traits – Business Insider

People who live the longest share these personality traits – Business Insider

Decades of research have linked specific personality traits to a longer life expectancy. Some of them — from friendliness to emotional stability — may…

Read More
2016 Global Board Survey Report – WomenCorporateDirectors

2016 Global Board Survey Report – WomenCorporateDirectors

What 4000+ corporate directors think about the economy, risk, board strengths and weaknesses, and boardroom diversity “Boards cannot afford to have directors around the…

Read More
Kevin Plank urges University of Maryland graduates to be passionate about reaching goals – Baltimore Sun

Kevin Plank urges University of Maryland graduates to be passionate about reaching goals – Baltimore Sun

Kevin Plank encourages University of Maryland graduates to let "passion" fuel their dreams Kevin Plank remembers sitting in his cap and gown at the…

Read More
NIH names Johns Hopkins a Center of Excellence for bioethics research – EurekAlert! Science News

NIH names Johns Hopkins a Center of Excellence for bioethics research – EurekAlert! Science News

The National Human Genome Research Institute of the National Institutes of Health (NIH) has awarded the Johns Hopkins Berman Institute of Bioethics a "Center…

Read More
Roche receives FDA Approval for novel PD-L1 biomarker assay

Roche receives FDA Approval for novel PD-L1 biomarker assay

Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced approval of the VENTANA PD-L1 (SP142) Assay1 by the US Food and Drug Administration (FDA) as…

Read More
How HHS is spurring data innovation both inside and outside the agency

How HHS is spurring data innovation both inside and outside the agency

It will be obvious when the Department of Health and Human Services’ IDEA Lab is a success, because it will no longer be needed, according to Damon Davis,…

Read More
J&J commits $740M for its second cancer R&D pact with MacroGenics – FierceBiotech

J&J commits $740M for its second cancer R&D pact with MacroGenics – FierceBiotech

Whatever Johnson & Johnson ($JNJ) learned about MacroGenics’ off-the-shelf approach to stirring a T cell attack against cancer since inking their first partnership deal…

Read More
Novartis splits drugs business into two, pharma chief to leave – Reuters

Novartis splits drugs business into two, pharma chief to leave – Reuters

Novartis is splitting its pharmaceuticals division into two business units, one focused on cancer and the second on other drugs, while switching out its…

Read More